Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

International Open-label Randomized Comparative Clinical Study of Efficacy and Safety of Clotrimazole+Lactulose, Vaginal Suppositories (AVVA RUS JSC, Russia) Vs. a Clotrimazole Monocomponent Product in Adult Female Patients with Candidal Vaginitis/vulvovaginitis

NCT06835361 is registered in ClinicalTrials.gov with AVVA Pharmaceuticals Ltd. as lead sponsor.

NCT NCT06835361
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06835361 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
International Open-label Randomized Comparative Clinical Study of Efficacy and Safety of Clotrimazole+Lactulose, Vaginal Suppositories (AVVA RUS JSC, Russia) Vs. a Clotrimazole Monocomponent Product in Adult Female Patients with Candidal Vaginitis/vulvovaginitis
Lead sponsor
AVVA Pharmaceuticals Ltd.
Phase
Phase 2/3
Overall status
Recruiting
Start date
February 29, 2024
Completion date
November 30, 2025
Enrollment
264 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

candidal vulvovaginitis (icd-10 code: b37.3), vulvovaginal candidiasis (vvc)